WARREN,
N.J., May 29, 2024 /PRNewswire/ -- PTC
Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company
will present a company overview at the following conference:
William Blair's
44th Annual Growth Stock Conference
Tuesday, June 4, at 9:00
am ET / 8:00 am CT
The presentation will be webcast live on the Events and
Presentations page under the Investor section of PTC Therapeutics'
website at https://ir.ptcbio.com/events-presentations and will
be archived for 30 days following the presentation. It is
recommended that users connect to PTC's website several minutes
prior to the start of the webcast to ensure a timely
connection.
About PTC Therapeutics, Inc.
PTC is a global
biopharmaceutical company focused on the discovery, development,
and commercialization of clinically differentiated medicines that
provide benefits to patients with rare disorders. PTC's ability to
globally commercialize products is the foundation that drives
investment in a robust and diversified pipeline of transformative
medicines and our mission to provide access to best-in-class
treatments for patients who have an unmet medical need. The
Company's strategy is to leverage its strong scientific expertise
and global commercial infrastructure to maximize value for its
patients and other stakeholders. To learn more about PTC, please
visit us at www.ptcbio.com and follow us on Instagram, Facebook,
Twitter, and LinkedIn.
For More Information:
Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original
content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-302157009.html
SOURCE PTC Therapeutics, Inc.